注射服务项目中丙型肝炎治疗的心理社会因素与照护级联
年龄和入组时已接受心理健康治疗与SVR相关,而活跃阿片使用患者中部分在治疗期间接受阿片使用障碍(OUD)治疗。
要点
- 完成DAA治疗的丙肝患者SVR率达89.6%。
- 年龄和入组时心理健康治疗与SVR相关。
- HCV治疗可能促进OUD治疗 engagement。
核心结论
- 在完成DAA治疗的注射吸毒者中,SVR率较高,但失访是主要挑战。
研究设计与样本
- 回顾性图表审查,纳入2015至2018年纽约市注射服务项目中102例确诊HCV病毒血症患者。
主要发现
- 年龄和入组时已接受心理健康治疗与SVR相关。
- 单变量分析中规律可卡因使用与SVR负相关,但调整年龄后无显著关联。
- 30例入组时有活跃非法阿片使用且完成DAA治疗者中,14例(46.4%)在治疗期间接受OUD治疗,9例在DAA完成后仍接受OUD治疗。
临床怎么用
- 在注射服务项目中整合HCV治疗可达到高SVR率。
- 心理健康治疗可能促进HCV治愈。
- HCV治疗可能促进OUD治疗和其他服务的参与。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) is highly effective. However, people who inject drugs face significant barriers to DAA access. METHODS: We describe a program that colocates HCV management within a syringe service program in New York City. We performed a retrospective chart review of all patients with confirmed HCV viremia. RESULTS: From 2015 to 2018, 102 patients with viremia completed intake. Fifty-eight patients started DAAs. Nine patients discontinued treatment or were lost to follow-up before completion; 1 is continuing DAA treatment. Of 48 patients who completed therapy, sustained virologic response (SVR) was achieved in 43 (89.6%). Age and established mental health treatment at intake were associated with SVR. Regular cocaine use was negatively associated with SVR in univariate analysis, but this association was not significant after adjustment for age. Of 30 patients completing DAA therapy with active illicit opioid use at intake, 14 (46.4%) engaged in opioid use disorder (OUD) treatment during therapy, and 9 remained in OUD treatment after completion of DAA treatment. CONCLUSIONS: Loss to follow-up is a challenge for people who inject drugs, but among those who completed treatment, SVR was achieved at a high rate. Mental health treatment may facilitate HCV cure. Conversely, HCV therapy may facilitate engagement in OUD treatment and other services.
引用
- Winetsky D, Burack D, Antoniou P, et al. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program. J Infect Dis. 2020. PMID: 32877544. doi:10.1093/infdis/jiaa142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。